0001096906-24-002227.txt : 20241206 0001096906-24-002227.hdr.sgml : 20241206 20241205213440 ACCESSION NUMBER: 0001096906-24-002227 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20241206 DATE AS OF CHANGE: 20241205 EFFECTIVENESS DATE: 20241206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AXIM BIOTECHNOLOGIES, INC. CENTRAL INDEX KEY: 0001514946 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 274092986 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-54296 FILM NUMBER: 241530376 BUSINESS ADDRESS: STREET 1: 6191 CORNERSTONE COURT, E STREET 2: SUITE 114 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (212) 751-0001 MAIL ADDRESS: STREET 1: 6191 CORNERSTONE COURT, E STREET 2: SUITE 114 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: AXIM INTERNATIONAL INC. DATE OF NAME CHANGE: 20110309 15-12G 1 axim_1512g.htm AXIM BIOTECHNOLOGIES, INC. FORM 15-12G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number:  000-54296

 

AXIM BIOTECHNOLOGIES, INC.

___________________________________________

(Exact name of registrant as specified in its charter)

 

6191 Cornerstone Court, E., Suite 114, San Diego, CA 92121, (858) 256-5132

____________________________________________________________________________________________

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, par value $.0001 per share

____________________________________________

(Title of each class of securities covered by this Form)

 

None

_________________________________________________________________________________

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or

15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)

☒

Rule 12g-4(a)(2)

☐

Rule 12h-3(b)(1)(i)

☒

Rule 12h-3(b)(1)(ii)

☐

Rule 15d-6

☐

Rule 15d-22(b)

☐

 

Approximate number of holders of record as of the certification or notice date: 109

 

Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

 

 

 

Date: December 5, 2024        /s/ Robert Malasek                                 

By:  Robert Malasek 

Its:  Chief Financial Officer